Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis

Marieke H. Otten, Femke H. M. Prince, Wineke Armbrust, Rebecca ten Cate, Esther P. A. H. Hoppenreijs, Marinka Twilt, Yvonne Koopman-Keemink, Simone L. Gorter, Koert M. Dolman, Joost F. Swart, J. Merlijn van den Berg, Nico M. Wulffraat, Marion A. J. van Rossum, Lisette W. A. van Suijlekom-Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2340-2347
JournalJAMA-Journal of the American Medical Association
Volume306
Issue number21
DOIs
Publication statusPublished - 7 Dec 2011

Cite this

Otten, M. H., Prince, F. H. M., Armbrust, W., ten Cate, R., Hoppenreijs, E. P. A. H., Twilt, M., Koopman-Keemink, Y., Gorter, S. L., Dolman, K. M., Swart, J. F., van den Berg, J. M., Wulffraat, N. M., van Rossum, M. A. J., & van Suijlekom-Smit, L. W. A. (2011). Factors Associated With Treatment Response to Etanercept in Juvenile Idiopathic Arthritis. JAMA-Journal of the American Medical Association, 306(21), 2340-2347. https://doi.org/10.1001/jama.2011.1671